Parallel Bio
The first map of human biology for drug discovery
Parallel Bio is a biotech company reimagining drug discovery by building a comprehensive map of human biology using human data instead of animal models. Their platform combines a growing biobank of patient samples with biological and computational tools to chart disease landscapes at population scale. They offer drug discovery, precision medicine, and foundation model capabilities to pharmaceutical partners, claiming 87% concordance with human outcomes and 10x faster timelines than traditional approaches.
Parallel Bio builds a biological atlas entirely from human patient data using novel biological and computational tools, enabling population-scale, perturbable modeling of disease landscapes without animal testing.
pharmaceutical companies and biotech researchers seeking human-first drug discovery
Background.
- Status
- launched
- Business model
- unknown
- Company
- Parallel Bio
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.